Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.0 has been applied, replacing the previous v3.4.3.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now shows a new revision tag v3.4.2 and removes the previous revision v3.4.1; core study details, eligibility criteria, and results remain unchanged.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. There are no visible changes to study details content or page layout.SummaryDifference0.1%

- Check78 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, reflecting a minor administrative update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedLocations section updated to include Seoul, Korea, Republic of as a study site. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.